These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30483055)

  • 1. RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A.
    Madero-Pérez J; Fernández B; Lara Ordóñez AJ; Fdez E; Lobbestael E; Baekelandt V; Hilfiker S
    Front Mol Neurosci; 2018; 11():417. PubMed ID: 30483055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Gómez-Suaga P; Waschbüsch D; Lobbestael E; Baekelandt V; Nairn AC; Ruiz-Martínez J; Aiastui A; López de Munain A; Lis P; Comptdaer T; Taymans JM; Chartier-Harlin MC; Beilina A; Gonnelli A; Cookson MR; Greggio E; Hilfiker S
    Mol Neurodegener; 2018 Jan; 13(1):3. PubMed ID: 29357897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits.
    Lara Ordónez AJ; Fernández B; Fdez E; Romo-Lozano M; Madero-Pérez J; Lobbestael E; Baekelandt V; Aiastui A; López de Munaín A; Melrose HL; Civiero L; Hilfiker S
    Hum Mol Genet; 2019 Nov; 28(21):3552-3568. PubMed ID: 31428781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
    Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network.
    Liu Z; Bryant N; Kumaran R; Beilina A; Abeliovich A; Cookson MR; West AB
    Hum Mol Genet; 2018 Jan; 27(2):385-395. PubMed ID: 29177506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease.
    Alexander KK; Naaldijk Y; Fasiczka R; Brahmia B; Chen T; Hilfiker S; Kennedy EJ
    J Pept Sci; 2024 May; 30(5):e3563. PubMed ID: 38135900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement.
    Fdez E; Madero-Pérez J; Lara Ordóñez AJ; Naaldijk Y; Fasiczka R; Aiastui A; Ruiz-Martínez J; López de Munain A; Cowley SA; Wade-Martins R; Hilfiker S
    iScience; 2022 Jun; 25(6):104476. PubMed ID: 35721463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.
    Rivero-Ríos P; Romo-Lozano M; Fernández B; Fdez E; Hilfiker S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32709066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LRRK2 signaling network converges on a centriolar phospho-Rab10/RILPL1 complex to cause deficits in centrosome cohesion and cell polarization.
    Lara Ordóñez AJ; Fasiczka R; Fernández B; Naaldijk Y; Fdez E; Blanca Ramírez M; Phan S; Boassa D; Hilfiker S
    Biol Open; 2022 Aug; 11(8):. PubMed ID: 35776681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72.
    Vieweg S; Mulholland K; Bräuning B; Kachariya N; Lai YC; Toth R; Singh PK; Volpi I; Sattler M; Groll M; Itzen A; Muqit MMK
    Biochem J; 2020 May; 477(9):1651-1668. PubMed ID: 32227113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 mediated Rab8a phosphorylation promotes lipid storage.
    Yu M; Arshad M; Wang W; Zhao D; Xu L; Zhou L
    Lipids Health Dis; 2018 Feb; 17(1):34. PubMed ID: 29482628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LRRK2 kinase substrates Rab8a and Rab10 contribute complementary but distinct disease-relevant phenotypes in human neurons.
    Mamais A; Sanyal A; Fajfer A; Zykoski CG; Guldin M; Riley-DiPaolo A; Subrahmanian N; Gibbs W; Lin S; LaVoie MJ
    bioRxiv; 2023 Apr; ():. PubMed ID: 37163109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients.
    Fernández B; Lara Ordóñez AJ; Fdez E; Mutez E; Comptdaer T; Leghay C; Kreisler A; Simonin C; Vandewynckel L; Defebvre L; Destée A; Bleuse S; Taymans JM; Chartier-Harlin MC; Hilfiker S
    Biochem J; 2019 Oct; 476(19):2797-2813. PubMed ID: 31527116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis.
    Eguchi T; Kuwahara T; Sakurai M; Komori T; Fujimoto T; Ito G; Yoshimura SI; Harada A; Fukuda M; Koike M; Iwatsubo T
    Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9115-E9124. PubMed ID: 30209220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.
    Naaldijk Y; Fernández B; Fasiczka R; Fdez E; Leghay C; Croitoru I; Kwok JB; Boulesnane Y; Vizeneux A; Mutez E; Calvez C; Destée A; Taymans JM; Aragon AV; Yarza AB; Padmanabhan S; Delgado M; Alcalay RN; Chatterton Z; Dzamko N; Halliday G; Ruiz-Martínez J; Chartier-Harlin MC; Hilfiker S
    NPJ Parkinsons Dis; 2024 Jan; 10(1):12. PubMed ID: 38191886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
    Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
    Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Parkinson's disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking.
    Kim MJ; Deng HX; Wong YC; Siddique T; Krainc D
    Hum Mol Genet; 2017 Feb; 26(4):729-741. PubMed ID: 28115417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.
    Blanca Ramírez M; Lara Ordóñez AJ; Fdez E; Madero-Pérez J; Gonnelli A; Drouyer M; Chartier-Harlin MC; Taymans JM; Bubacco L; Greggio E; Hilfiker S
    Hum Mol Genet; 2017 Jul; 26(14):2747-2767. PubMed ID: 28453723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.
    Dzamko N; Chua G; Ranola M; Rowe DB; Halliday GM
    J Parkinsons Dis; 2013; 3(2):145-52. PubMed ID: 23938344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.